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Abstract: 
Objectives  
The aim of this study was to investigate the presence of naturally occurring 
antibodies against canine erythrocyte antigens in cats, and vice versa. The 
influence of canine and feline blood type on cross-match results was also 
studied.  
Methods  
Blood samples from 34 cats and 42 dogs were used to perform test-tube 
major and minor cross-match tests and blood typing. Blood from each cat 
was cross-matched with blood from two to six dogs, for a total of 111 
cross-match tests. Hemolysis, macro- and/or micro-agglutination were 
considered markers of a positive cross-match.  
Results  
Eighty-three overall major cross-match tests were positive at 37°C, 86 at 
room temperature and 90 at 4°C.  The minor cross-match tests were 
positive in all but two cross-matches performed at 37°C, all tests 
performed at room temperature and all but one test performed at 4°C. No 
cats tested totally negative at both major and minor cross-matches 
performed with samples from any single dog.  Prevalence of warm natural 
antibodies against canine erythrocyte antigens was lower in type B cats 
compared to A, regardless of the blood type of donor dogs.  
Conclusions and relevance  
This study reveals a high prevalence of naturally-occurring antibodies in 
cats against dog erythrocyte antigens, and vice versa, and suggests that 
transfusion of cats with canine blood is not recommended as a routine 
procedure due to the potential high risk of either acute severe or milder 
transfusion reactions.   
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Acceptable for publication with minor grammatical corrections only.  
 
Minor corrections are written on scanned copy for use by authors and editor. 
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We changed “cross-matching” to “cross-match” as suggested at lines 22 and 33 and also in the whole 
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Line 58:  Say "(such as the Mik system)" 
ANSWER: done 
 
Line 282:  Say "...does not predict an absence of reactions against leukocytes...." 
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Line 293: Say "....or that the prevalence of alloantibodies and feline blood types vary....." 
ANSWER: done 
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Abstract 18 
Objectives 19 
The aim of this study was to investigate the presence of naturally occurring 20 
antibodies against canine erythrocyte antigens in cats, and vice versa. The 21 
influence of canine and feline blood type on cross-match results was also 22 
studied.  23 
Methods 24 
Blood samples from 34 cats and 42 dogs were used to perform test-tube major 25 
and minor cross-match tests and blood typing. Blood from each cat was cross-26 
matched with blood from two to six dogs, for a total of 111 cross-match tests. 27 
Hemolysis, macro- and/or micro-agglutination were considered markers of a 28 
positive cross-match.  29 
Results 30 
Eighty-three overall major cross-match tests were positive at 37°C, 86 at room 31 
temperature and 90 at 4°C.  The minor cross-match tests were positive in all but 32 
two cross-matches performed at 37°C, all tests performed at room temperature 33 
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and all but one test performed at 4°C. No cats tested totally negative at both 34 
major and minor cross-matches performed with samples from any single dog.  35 
Prevalence of warm natural antibodies against canine erythrocyte antigens was 36 
lower in type B cats compared to A, regardless of the blood type of donor dogs. 37 
Conclusions and relevance  38 
This study reveals a high prevalence of naturally-occurring antibodies in cats 39 
against dog erythrocyte antigens, and vice versa, and suggests that transfusion 40 
of cats with canine blood is not recommended as a routine procedure due to the 41 
potential high risk of either acute severe or milder transfusion reactions.  42 
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Introduction 43 
Two feline blood group systems are known: AB (comprising types A, B and 44 
AB), and Mik (including types Mik positive and Mik negative).1 Type A cats 45 
may have weak natural anti-B alloantibodies. In contrast type B cats have 46 
strong natural anti-A alloantibodies, causing acute, severe hemolytic reactions 47 
against type A erythrocytes. Type AB cats do not have natural alloantibodies.2 48 
The Mik blood group system was recently identified in USA.3 Mik negative cats 49 
can have naturally occurring anti-Mik alloantibodies that elicit acute hemolytic 50 
transfusion reactions.3 Therefore accurate identification of blood types is 51 
important in feline practice to reduce the possibility of potentially fatal 52 
transfusion reactions and obtain the best efficacy from blood transfusions.4 53 
While several feline AB typing kits are commercially available for clinical 54 
practice, typing of AB and B cats can still pose challenges because erroneous 55 
and discordant blood typing results have been reported in cats.4,5 Furthermore, 56 
they cannot account for antigens outside of the AB system (such as the Mik 57 
system) nor for alloantibodies present in the recipient.6 The prevalence of non-58 
AB blood types is unknown at present. Two recent studies, based on a limited 59 
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number of cats, did not find evidence for non-AB blood type incompatibilities.4,6 60 
When possible, cross-match (XM) that detects recipient antibodies against 61 
donor erythrocytes (major XM) and donor antibodies against recipient 62 
erythrocytes (minor XM) should be performed prior to transfusion to increase 63 
patient safety.2,6 64 
Blood transfusion in the feline species may be challenging. In fact, the small size 65 
of donors makes blood collection technically more difficult than in dogs, and 66 
sedation is usually required for bleeding donors. Moreover, the high prevalence 67 
of naturally-occurring alloantibodies against feline red blood cell (RBC) 68 
antigens demands that blood typing is performed before any transfusion, and 69 
the need to use donors and recipients of the same blood type can make 70 
transfusions difficult in cats with rare blood types, such as B or AB.1,2,7  71 
Despite xenotransfusions being abandoned in all other domestic species since 72 
the early 1900s, transfusion of canine blood to cats is still performed in 73 
veterinary practice as a life-saving procedure when hemoglobin-based oxygen 74 
carrier solutions are not available and a suitable feline donor cannot be 75 
found.5,8,9,10  76 
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Based on a limited number of cases reported in the veterinary literature, with 77 
most publications dating from 1960s, cats did not appear to have naturally-78 
occurring antibodies against canine RBC antigens.8 However, a recent study 79 
reported significant incompatibilities detected by XM between feline and canine 80 
blood.5 No severe acute adverse reactions have been described  for cats 81 
receiving a single transfusion with canine blood.5,8,9,11,12  Only mild transfusion 82 
reactions occasionally occurred during the transfusion or in the following 83 
week.5,8  In most reports, cats transfused with canine blood improved 84 
clinically.5,9,10,13 However, antibodies against canine RBCs were produced within 85 
4-21 days of the transfusion, and any repeated transfusion with canine blood 86 
later than 6 days after the first one caused severe acute reactions which were 87 
frequently fatal.8,11,12  Moreover, the lifespan of the transfused canine RBCs was 88 
very short (3-5 days).5,14   89 
Because of the limited number of cases reported in the literature, more data are 90 
needed to evaluate the benefit and the risks of dog-to-cat xenotransfusions.  91 
The purpose of this study was to assess the potential risk of adverse transfusion 92 
reactions in cats transfused with canine blood, by evaluating the occurrence of 93 
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feline naturally occurring antibodies against canine RBC antigens and vice versa. 94 
The influence of blood types of cats and dogs on XM results was also 95 
investigated. 96 
Materials and methods 97 
Samples 98 
Surplus material from diagnostic samples of 34 domestic shorthair cats and 42 99 
dogs of 17 different breeds admitted to the Teaching Veterinary Hospital of 100 
University of Messina for elective surgery, annual health check or health 101 
problems between February and November 2015 was used. Informed consent 102 
was obtained from owners and results from blood typing were offered to them 103 
free of charge. About 1 mL of K2EDTA-blood and, when available, up to 1 mL 104 
of blood serum were used to perform blood typing and XM tests. Hemolyzed 105 
samples were excluded from the study. Blood was stored at 4°C until use and 106 
was brought to room temperature (RT) before testing. Cross-match and canine 107 
blood typing were performed within 24 hours after blood collection. Feline 108 
blood typing was performed within a week after blood collection. 109 
Page 9 of 29
http://mc.manuscriptcentral.com/jfms
Journal of Feline Medicine and Surgery
For Peer Review
8 
Blood typing 110 
The canine DEA 1 system was typed using a commercial immuno-111 
chromatographic test (Lab test DEA1- Alvedia, Limonest, France) according to 112 
the manufacturer procedure.  113 
Blood typing of all cats was determined at Veterinary Transfusion Research 114 
Laboratory (REVLab) Unit, Department of Veterinary Medicine, University of 115 
Milan, Italy using a tube agglutination method and confirmed with a back-116 
typing technique.15 EDTA-blood (150 μL) was centrifuged for 2 mins at 1,000 x 117 
g at RT. Plasma was removed and the RBC pellet was resuspended in 5 mL of 118 
saline solution (0.9% NaCl) and washed three times by repeating centrifugation, 119 
discharge of supernatant and addition of PBS. Finally, 25 μL of a 5% RBCs PBS 120 
suspension were put in three tubes and mixed respectively with: 50 μL of type 121 
B serum (anti-A reagent), 8 μg of Triticum vulgaris lectin/mL in PBS solution 122 
(anti-B reagent), or saline solution (0.9% NaCl). These mixtures were incubated 123 
at RT for 15 mins before centrifugation for 15 s at 1,000 × g. Tubes were then 124 
gently shaken, checked for agglutination and considered positive if 125 
macroscopic agglutinates were observed. The cats were considered type A if 126 
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agglutination was detected in the tube containing anti-A reagent, type B when 127 
agglutination was observed in the tube containing anti-B reagent, and type AB 128 
if agglutination was seen in both tubes. Alloantibody testing was performed in 129 
all type B or AB samples to detect the presence or absence of alloantibodies. 130 
When a sample appeared to be AB or B, it was confirmed with the back typing 131 
technique: washed 5% RBC suspension from the test sample, a known type A 132 
cat and a known type B cat were incubated with the plasma sample as 133 
described for tube agglutination to detect the presence (in type B cats versus 134 
type A RBCs) or absence (in type AB cats either versus type A and type B RBCs) 135 
of alloantibodies. 136 
Cross-match tests  137 
Cross-match procedures were always performed by the same experienced 138 
technicians, and checked by one of authors (MM).16,17   139 
K2EDTA tubes were centrifuged to separate RBCs from plasma, which were 140 
transferred to separate tubes. Cat (recipient) and dog (donor) RBCs were 141 
washed three times by adding about 1 ml of saline solution (0.9% NaCl), mixing 142 
gently and centrifuging at 1,000 x g for 1 min, then removing supernatant. Five 143 
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percent donor and recipient RBC suspensions in saline solution were then 144 
prepared. When the amount of left over samples was scant, priority was given 145 
to perform major XM testing, and to perform incubations at 37°C because both 146 
these evaluations are considered more relevant for predicting severe post-147 
transfusion reactions in the recipient animal.17 EDTA plasma was used when 148 
serum was insufficient or hemolytic. 149 
Major cross-match 150 
An equal amount of donor RBC suspension and recipient serum or plasma were 151 
placed in three tubes, mixed and incubated respectively at 4°C and RT for 30 152 
mins, and at 37°C for 15 mins.16 The tubes were then centrifuged at 115 x g for 1 153 
min and the supernatant was evaluated for hemolysis. Tubes were then shaken 154 
gently to re-suspend cells and check for macroagglutination. If no obvious 155 
agglutination was observed in the tube, one drop of blood suspension was 156 
placed on a glass slide and examined for evidence of microagglutination. 157 
Hemolysis, macro and/or microagglutination were considered markers of a 158 
positive XM. 159 
Minor cross-match, donor and recipient controls 160 
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Minor XM, donor and recipient controls were respectively performed as 161 
described for major XM by mixing recipient RBC suspension and donor serum 162 
or plasma (minor XM), donor RBC suspension and donor serum or plasma 163 
(donor control), or recipient RBC suspension and recipient serum or plasma 164 
(recipient control). The controls were performed for all samples, apart from one 165 
cat, and only at RT.  166 
 Statistical analyses 167 
Statistical analyses were performed using the GraphPad InStat v3.05 statistic 168 
program (GraphPad Software Inc., San Diego California, USA, 2000) for 169 
Windows 95. The Fisher’s exact test was used to determine whether there were 170 
statistical differences: a) in frequency of hemolysis or agglutination according to 171 
temperature of incubation, both in the major XM and minor XM tests; b) in 172 
frequency of positive results (hemolysis and/or agglutination) according to the 173 
recipient and donor blood type in the major XM test at the three temperatures 174 
of incubation. P values ≤ 0.05 were considered significant.  175 
Results 176 
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Blood typing 177 
Fifteen dogs were DEA1 negative, 12 were DEA1 strong positive and 15 were 178 
DEA1 weak positive.18 179 
Twenty-seven cats were type A, three type B and four type AB. All type B and 180 
AB samples were confirmed by back typing. 181 
Cross-match tests 182 
Blood from each cat was cross-matched with blood from a variable number of 183 
dogs ranging from two to six, for a total of 111 cross-matches. Ninety-seven 184 
complete XM tests including major XM and minor XM at the three different 185 
temperatures of incubation were obtained. Major XM was not performed in 186 
seven cases at both 4°C and RT, and minor XM was not done in 10 cases at 4°C 187 
and RT and in four cases at 37°C. Eighty-three/111 (74.8%) overall major XM 188 
tests proved positive at 37°C, 86/104 (82.6%) at RT and 90/104 (86.5%) at 4°C. 189 
Details about detection of hemolysis and/or agglutination are given in Table 1. 190 
The minor XM tests were positive in all but two XMs performed at 37°C 191 
(98.1%), all tests performed at RT (100%) and all but one test performed at 4°C 192 
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(99%). Details about detection of hemolysis and/or agglutination are given in 193 
Table 2. No cats tested totally negative for both major XM and minor XM 194 
procedures performed using samples from any single matched dog. Major XM 195 
was negative at all three temperatures only in 2/104 (1.9%) tests, was negative at 196 
both 37°C and RT in 9/104 (8.6%) tests, and was negative at 37°C only in 28/111 197 
(25.2%) tests. In major XM tests, hemolysis was significantly more frequent at 198 
37°C (21/111=18.9%) compared to RT (9/104=8.6%) (P=0.032) and 4°C 199 
(5/104=4.8%) (P= 0.0015). Conversely, agglutination was significantly more 200 
frequent at 4°C (88/104= 84.6%) compared to 37°C (71/111=63.9%) (P= 0.0006), 201 
and at RT (81/104= 77.9%) compared to 37°C (P= 0.0354). For minor XM tests, 202 
there was no significant difference in frequency of hemolysis or agglutination 203 
according to temperatures of incubation. 204 
Cross-match of each single cat showed different patterns of compatibility 205 
towards the two to six tested canine samples. 206 
Cross-match results based on feline and canine blood type typing 207 
Results of major XM based on canine and feline blood types are reported in 208 
Table 3. Significant differences were found only at 37°C for the two following 209 
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combinations: a) feline type A with canine DEA1 strong positive (positive 210 
reactions: 31/36=86.1%) in comparison to feline type B with canine DEA1 strong 211 
positive (positive reactions: 2/6=33.3%) (P=0.01); b) feline type A with canine 212 
DEA1 strong positive (positive reactions: 31/36=86.1%) in comparison to feline 213 
type B with canine DEA1 negative (positive reactions: 1/4= 25%) (P=0.02). 214 
Discussion 215 
This study reveals a high prevalence of naturally occurring antibodies in cats 216 
against dog erythrocyte antigens, and vice versa. In fact, no tested cat was totally 217 
negative for hemolysis and/or agglutination for both major and minor XM 218 
procedures performed at 4°C, RT and 37°C with samples from any single dog. 219 
The presence of hemolysis or agglutination on major and minor XM testing 220 
implies that the recipient is not compatible, respectively, to the donor’s RBCs or 221 
to the donor’s plasma.19 The presence of macroagglutination and hemolysis on 222 
major XM precludes the use of the donor’s RBCs because it indicates that, in the 223 
recipient, a severe adverse acute transfusion reaction may occur.11,20 Conversely, 224 
the presence of microagglutination may not necessarily indicate that the patient 225 
will have a severe adverse transfusion reaction.15   It is commonly accepted that 226 
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blood for transfusion ideally should be compatible at 37°C and RT, but major 227 
XM at 37°C is clinically the most important compatibility.17 However, cold (4°C) 228 
incompatibilities can cause microthrombosis in acral capillary beds and 229 
therefore potentially ischemic necrosis of the tip of ears, nose or tail during cold 230 
weather.21 231 
In 57.6% (64/111) of major XM tests that we performed at 37°C, hemolysis 232 
and/or macroagglutination were found, suggestive of a high risk of severe acute 233 
transfusion reactions.17 Moreover, feline hemolysins against dog RBCs were 234 
more prevalent at 37°C, conversely hemoagglutinins were more prevalent at 235 
4°C. A limitation of this study is the lack of controls at 4°C and at 37°C, due to 236 
the restricted amount of available blood. Because of this, positive results at 237 
these incubation temperatures could have been overestimated. Furthermore, 238 
hemolytic reactions could have been underestimated when XMs were 239 
performed using plasma obtained from EDTA blood. In fact, complement 240 
activation is responsible for in vitro hemolysis after anti-RBC antibodies reacted 241 
with RBC antigens, but it cannot occur when calcium and magnesium cations 242 
are chelated by EDTA.22 243 
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Further limitations of this study are that we did not test cats for the Mik system 244 
group, and we had the opportunity to test very few feline type B and AB 245 
samples because of their low prevalence in the feline population.23,24 However, 246 
the prevalence of warm natural antibodies against canine RBCs was lower in 247 
type B cats compared to type A only when matched with DEA1 strong positive 248 
blood. We can therefore assume that type A cats more frequently have warm 249 
natural antibodies against DEA1 strong positive RBCs and could have a higher 250 
risk for severe acute adverse reactions after xenotransfusion with DEA1 strong 251 
positive donors. 252 
Almost all minor XM tests in this study were positive, and mostly agglutination 253 
reactions were detected. When the volume of donor plasma transfused is small, 254 
antibodies in donor plasma become significantly diluted in the recipient blood 255 
stream, and therefore the results of the minor XM test may not be clinically 256 
relevant or may cause mild to moderate acute transfusion reactions.17 However 257 
transfusion of large amounts of canine whole blood containing antibodies 258 
against the recipient’s RBCs may cause severe hemolysis and worsen a pre-259 
existing anemia.8 This could occur as a result of repeated whole blood 260 
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transfusions in subsequent days or of  administration of large amounts of 261 
plasma. 262 
Extensive data about pre-transfusion dog-to-cat XM tests are not available. In 263 
fact, published studies report information regarding XM tests in about 56 cases 264 
only.5,8 Nineteen cats showed agglutination against canine red blood cells on 265 
major XM, and in only two cases on minor XM.8 Unfortunately, all these tests 266 
were performed at one temperature of incubation only:  RT or 37°C. Moreover, 267 
minor XM, microagglutination or hemolysis were usually not evaluated.5,8,11 268 
Microagglutination and incompatibility reactions in major XM at RT or in 269 
minor XM can cause milder reactions and reduce the survival of transfused red 270 
blood cells. This could be the reason why mild transfusion reactions have 271 
previously been reported occasionally during the transfusion or in the 272 
following week.8,20 Furthermore, in some studies the lifespan of transfused 273 
canine RBCs was shortened to less than 4-5 days compared to a 30 days half-life 274 
for compatible feline RBCs 5,14,25 275 
Negative major and/or minor XM tests do not completely eliminate the risk 276 
associated with transfusions, and do not guarantee an expected lifespan of 277 
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transfused erythrocytes, because delayed reactions can be caused by the 278 
production of antibodies against RBC antigens shortly after the transfusion.26 279 
Additionally, a negative RBC XM test does not predict an absence of reactions 280 
against leukocytes and plasma proteins.26 Therefore, although XM tests are 281 
considered to be the standard test for assessing the risk of blood transfusion 282 
due to immunological reactions in practice, they are not fully predictive of the 283 
risk of transfusion reactions.5 284 
This study, as also recently found by Euler et al (2016), consistently shows a 285 
high degree of incompatibility when dog and cat blood are cross-matched. 286 
Despite this, reports of acute transfusion reactions on first transfusion of dog 287 
blood to cats are rare, according to both publications dating from the 1960s and 288 
a few recent case reports.5,9,10,11,12,13,25  The discrepancy between multiple reported 289 
safe dog-to-cat transfusions and consistent XM incompatibility could be due to 290 
the fact that natural alloantibodies have changed over time, or that the 291 
prevalence of alloantibodies and feline blood types vary in different geographic 292 
areas, or that the older studies missed minor transfusion reactions. Finally, a 293 
low positive predictive value for adverse xenotransfusion reactions following 294 
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incompatible dog-cat XM cannot be excluded, but this positive predictive value 295 
cannot be explored in clinical settings, because blood is almost never transfused 296 
when a positive XM is obtained and, in emergency situations, cats are 297 
presumably transfused without performing XM with the donor dog. 298 
Conclusions 299 
Transfusion of cats with canine blood is not recommended as a routine 300 
procedure because the high prevalence of XM incompatibilities theoretically 301 
suggests an elevated risk of severe acute reactions or of milder reactions that 302 
make the xenotransfusion less beneficial than transfusion with matched feline 303 
whole blood.  In exceptional circumstances where xenotransfusion is the only 304 
means available for the short-term stabilization of a feline patient until 305 
obtaining compatible feline blood or bone marrow red cell regeneration, XM 306 
tests should always be performed.  A completely compatible canine blood 307 
might be extremely difficult to find and, in this case, dogs found negative at 308 
major XM (best at 37°C) would be preferred.  309 
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Tables 1 
Table 1: Results (agglutination and/or hemolysis) of major XM test at the three temperatures of incubation. 2 
The number of agglutinations detected microscopically only is indicated in brackets 3 
Type of result     4°C       RT     37°C 
Negative for hemolysis and 
agglutination   14/104     18/104    28/111  
Hemolysis positive and 
agglutination negative     2/104      5/104    12/111  
Hemolysis negative and 
agglutination positive   85/104 (13)   77/104(12)    62/111 (18)  
Positive for hemolysis and 
agglutination    3/104  (1)     4/104  (0)     9/111  (1)  
Total       104 (14)       104 (12)        111 (19) 
 4 
  5 
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Table 2: Results (agglutination and/or hemolysis) of minor XM at the three temperatures of incubation. The 6 
number of agglutinations detected microscopically only is indicated in brackets. *This denominator is less 7 
than the total number reported in the column because in some cases all RBCs were destroyed by hemolysis, 8 
and it was not possible to evaluate agglutination  9 
Type of result 4°C RT 37°C 
Negative for hemolysis and 
agglutination 
 
1/101 0/101 2/107 
Hemolysis positive and 
agglutination negative 
 
1/95* 1/90* 0/96* 
Hemolysis negative and 
agglutination positive 
 
75/101(4) 74/101(1) 66/107(2) 
Positive for hemolysis and 
agglutination 
 
18/101 (0) 15/101 (0) 28/107 (0) 
Total 101 (4) 101 (1) 107 (2) 
 10 
  11 
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 3 
Table 3: Results of major XM tests at the three temperatures of incubation according to feline blood type and 12 
DEA classification of canine blood. P: positive hemolysis and/or agglutination; N: negative hemolysis and 13 
agglutination, BT: blood type 14 
Cat BT  Dog BT 4°C RT             37°C 
  P N P N P            N 
A DEA 1 
Strong + 
29(90.6%) 3 27(84.4%) 5 31(86.1%) 5 
B DEA 1 
Strong + 
6(100%) 0 4 (80%) 1 2 (33.3%) 4 
AB DEA 1 
Strong + 
6(100%) 0 6(100%) 0 5 (83.3%) 1 
A DEA 1 
Weak + 
17(77.3%) 5 18 (81.8%) 4 18(75%) 6 
B DEA 1 
Weak + 
2(100%) 0 2(100%) 0 2(100%) 0 
AB DEA 1 
Weak + 
4(80%) 1  5(100%) 0 4(80%) 1 
A DEA 1 
Negative 
20(80%) 5 21(84%) 4 18(72%) 7 
B DEA 1 
Negative 
4(100%) 0 2(50%) 2 1(25%) 3 
AB DEA 1 
Negative 
3(100%) 0 1(33.3%) 2 1(33.3%) 2 
 15 
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